Completed PHASE2 INTERVENTIONAL NCT00000471

Lifestyle Heart Trial

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Cardiovascular Diseases Coronary Arteriosclerosis Coronary Disease Heart Diseases Hypercholesterolemia Hypertension Myocardial Ischemia

Interventions diet, fat-restricted diet, vegetarianism exercise smoking cessation

Updated 5 times since 2017 Last updated: Dec 12, 2013 Started: Apr 30, 1989 Completion: Mar 31, 1993

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cardiovascular Diseases and Coronary Arteriosclerosis and is currently completed. National Heart, Lung, and Blood Institute (NHLBI) leads this study, which shows 5 recorded versions since 1989 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 1989

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.